US Bancorp’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $517K | Buy |
1,636
+425
| +35% | +$100K | ﹤0.01% | 1548 |
|
|
2026
Q1 | $242K | Sell |
1,211
-25
| -2% | -$4.95K | ﹤0.01% | 1914 |
|
|
2025
Q4 | $234K | Sell |
1,236
-160
| -11% | -$30.7K | ﹤0.01% | 1947 |
|
|
2025
Q3 | $247K | Sell |
1,396
-2,377
| -63% | -$353K | ﹤0.01% | 1891 |
|
|
2025
Q2 | $429K | Sell |
3,773
-286
| -7% | -$30.6K | ﹤0.01% | 1589 |
|
|
2025
Q1 | $427K | Buy |
4,059
+3,301
| +435% | +$373K | ﹤0.01% | 1574 |
|
|
2024
Q4 | $81.2K | Buy |
758
+98
| +15% | +$11.1K | ﹤0.01% | 2497 |
|
|
2024
Q3 | $66.1K | Buy |
660
+12
| +2% | +$1.21K | ﹤0.01% | 2596 |
|
|
2024
Q2 | $54.6K | Sell |
648
-12
| -2% | -$955 | ﹤0.01% | 2620 |
|
|
2024
Q1 | $48.2K | Buy |
660
+48
| +8% | +$3.54K | ﹤0.01% | 2721 |
|
|
2023
Q4 | $43.7K | Buy |
612
+531
| +656% | +$31.3K | ﹤0.01% | 2739 |
|
|
2023
Q3 | $4.85K | Sell |
81
-194
| -71% | -$12.8K | ﹤0.01% | 3442 |
|
|
2023
Q2 | $19.8K | Sell |
275
-6
| -2% | -$450 | ﹤0.01% | 2983 |
|
|
2023
Q1 | $20.7K | Buy |
281
+245
| +681% | +$17.4K | ﹤0.01% | 2973 |
|
|
2022
Q4 | $2.4K | Sell |
36
-47
| -57% | -$3.06K | ﹤0.01% | 3727 |
|
|
2022
Q3 | $5K | Sell |
83
-21
| -20% | -$1.23K | ﹤0.01% | 3596 |
|
|
2022
Q2 | $6K | Sell |
104
-13
| -11% | -$738 | ﹤0.01% | 3529 |
|
|
2022
Q1 | $8K | Sell |
117
-383
| -77% | -$27.8K | ﹤0.01% | 3460 |
|
|
2021
Q4 | $48K | Buy |
500
+70
| +16% | +$6.47K | ﹤0.01% | 2682 |
|
|
2021
Q3 | $38K | Sell |
430
-961
| -69% | -$74.3K | ﹤0.01% | 2782 |
|
|
2021
Q2 | $114K | Sell |
1,391
-76
| -5% | -$6.32K | ﹤0.01% | 2241 |
|
|
2021
Q1 | $140K | Buy |
1,467
+944
| +180% | +$89.2K | ﹤0.01% | 2084 |
|
|
2020
Q4 | $32K | Sell |
523
-1,495
| -74% | -$85.2K | ﹤0.01% | 2703 |
|
|
2020
Q3 | $120K | Sell |
2,018
-72
| -3% | -$4.91K | ﹤0.01% | 1999 |
|
|
2020
Q2 | $146K | Sell |
2,090
-972
| -32% | -$61.6K | ﹤0.01% | 1920 |
|
|
2020
Q1 | $139K | Sell |
3,062
-96
| -3% | -$5.44K | ﹤0.01% | 1863 |
|
|
2019
Q4 | $206K | Sell |
3,158
-470
| -13% | -$31.4K | ﹤0.01% | 1804 |
|
|
2019
Q3 | $225K | Sell |
3,628
-1,532
| -30% | -$96.2K | ﹤0.01% | 1746 |
|
|
2019
Q2 | $367K | Sell |
5,160
-361
| -7% | -$26.6K | ﹤0.01% | 1555 |
|
|
2019
Q1 | $433K | Sell |
5,521
-10,454
| -65% | -$792K | ﹤0.01% | 1446 |
|
|
2018
Q4 | $1.35M | Buy |
15,975
+3,422
| +27% | +$365K | ﹤0.01% | 876 |
|
|
2018
Q3 | $2.15M | Sell |
12,553
-5,288
| -30% | -$797K | 0.01% | 777 |
|
|
2018
Q2 | $2.31M | Buy |
17,841
+1,468
| +9% | +$164K | 0.01% | 750 |
|
|
2018
Q1 | $1.69M | Sell |
16,373
-1,225
| -7% | -$121K | 0.01% | 849 |
|
|
2017
Q4 | $1.5M | Buy |
17,598
+3,923
| +29% | +$340K | ﹤0.01% | 910 |
|
|
2017
Q3 | $1.16M | Buy |
13,675
+7,032
| +106% | +$557K | ﹤0.01% | 1004 |
|
|
2017
Q2 | $503K | Buy |
6,643
+479
| +8% | +$33.5K | ﹤0.01% | 1405 |
|
|
2017
Q1 | $407K | Buy |
6,164
+108
| +2% | +$7.11K | ﹤0.01% | 1474 |
|
|
2016
Q4 | $384K | Buy |
6,056
+1,537
| +34% | +$97K | ﹤0.01% | 1491 |
|
|
2016
Q3 | $287K | Buy |
4,519
+2,262
| +100% | +$166K | ﹤0.01% | 1597 |
|
|
2016
Q2 | $168K | Buy |
2,257
+955
| +73% | +$70.9K | ﹤0.01% | 1773 |
|
|
2016
Q1 | $87K | Buy |
1,302
+18
| +1% | +$1.09K | ﹤0.01% | 2088 |
|
|
2015
Q4 | $87K | Buy |
1,284
+242
| +23% | +$14.9K | ﹤0.01% | 2147 |
|
|
2015
Q3 | $55K | Buy |
1,042
+111
| +12% | +$6.74K | ﹤0.01% | 2405 |
|
|
2015
Q2 | $59K | Buy |
931
+110
| +13% | +$6K | ﹤0.01% | 2451 |
|
|
2015
Q1 | $40K | Sell |
821
-189
| -19% | -$7.24K | ﹤0.01% | 2651 |
|
|
2014
Q4 | $34K | Sell |
1,010
-1,473
| -59% | -$47.9K | ﹤0.01% | 2704 |
|
|
2014
Q3 | $73K | Sell |
2,483
-5,162
| -68% | -$171K | ﹤0.01% | 2275 |
|
|
2014
Q2 | $297K | Sell |
7,645
-659
| -8% | -$26.7K | ﹤0.01% | 1618 |
|
|
2014
Q1 | $348K | Buy |
8,304
+1,988
| +31% | +$82.9K | ﹤0.01% | 1500 |
|
|
2013
Q4 | $206K | Buy |
6,316
+4,631
| +275% | +$151K | ﹤0.01% | 1708 |
|
|
2013
Q3 | $45K | Buy |
+1,685
| New | +$47.4K | ﹤0.01% | 2376 |
|
Other funds holding LGND
JT
CAM
US Bancorp's LGND Position: Q2 2026 in Review
US Bancorp increased its Ligand Pharmaceuticals (LGND) stake by 35% in Q2 2026, buying an estimated $100K and bringing the position to 1,636 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.
US Bancorp first reported a position in LGND in Q3 2013 and has held it in 52 quarters since. The position peaked at $2.31M in Q2 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- US Bancorp held 1,636 shares of Ligand Pharmaceuticals worth $517K as of Q2 2026.
- US Bancorp bought 425 Ligand Pharmaceuticals shares in Q2 2026, an estimated $100K.
- Ligand Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1548 holding.
- US Bancorp first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- US Bancorp's Ligand Pharmaceuticals position peaked at $2.31M in Q2 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.